Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders

NCT02247427
completed

PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure

NCT00279955
completed

Ensure Cardiac Resynchronization Therapy Study

NCT00291564
completed

InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy

NCT00289302

Clinical Trials (4)

Showing 4 of 4 trials
NCT02247427Phase 2

Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders

Completed
NCT00279955

PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure

Completed
NCT00291564

Ensure Cardiac Resynchronization Therapy Study

Completed
NCT00289302

InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4